相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF
K-J Choi et al.
GENE THERAPY (2012)
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
I-K Choi et al.
GENE THERAPY (2011)
Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
Song-Nan Zhang et al.
MOLECULAR THERAPY (2011)
Enrichment of CCR6(+)Foxp3(+) regulatory T cells in the tumor mass correlates with impaired CD8(+) T cell function and poor prognosis of breast cancer
Lin Xu et al.
CLINICAL IMMUNOLOGY (2010)
Oncolytic adenoviruses expressing interleukin: a novel antitumour approach
Dong-Sheng Pei et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
Jing-Hua Huang et al.
MOLECULAR THERAPY (2010)
Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response
J. Reay et al.
CANCER GENE THERAPY (2009)
Interleukin 12 Stimulates IFN-γ-Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance
Xuefang Cao et al.
CANCER RESEARCH (2009)
Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses
Edukulla Ramakrishna et al.
CANCER RESEARCH (2009)
Oncolytic virotherapy as a personalized cancer vaccine
Qi-Xiang Li et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
Diego O. Croci et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus specific immune response
Jeroen N. Stoop et al.
HEPATOLOGY (2007)
E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects
Jaesung Kim et al.
HUMAN GENE THERAPY (2007)
Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12
Teruo Kaiga et al.
JOURNAL OF IMMUNOLOGY (2007)
Cytokine gene transfer for cancer therapy
Osvaldo L. Podhajcer et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2007)
Regulatory T cells and cancer
Helen Y. Wang et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect
K-J Choi et al.
GENE THERAPY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects
O Shimozato et al.
IMMUNOLOGY (2006)
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
CA Hunter
NATURE REVIEWS IMMUNOLOGY (2005)
PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis
D Elias et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2, macrophages subvert, immunity to (myco)bacteria
FAW Verreck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tolerance and cancer: Mechanisms of tumor evasion and strategies for breaking tolerance
MY Mapara et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy
A Harari et al.
BLOOD (2004)
Cytokines in cancer immunity and immunotherapy
MJ Smyth et al.
IMMUNOLOGICAL REVIEWS (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Effective immunotherapy against cancer - A question of overcoming immune suppression and immune escape?
KJ Malmberg
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Serum tumor markers in the management of ovarian, endometrial and cervical cancer
A Gadducci et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity
SA Younes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions
H Mizuguchi et al.
HUMAN GENE THERAPY (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R
C Parham et al.
JOURNAL OF IMMUNOLOGY (2002)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
TNF-α and IL-12:: a balancing act in macrophage functioning
XJ Ma
MICROBES AND INFECTION (2001)
Crucial role of TNF-α in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo
A Prévost-Blondel et al.
JOURNAL OF IMMUNOLOGY (2000)
Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients
T Helms et al.
JOURNAL OF IMMUNOLOGY (2000)
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients
N Haicheur et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)